We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

109 hedge funds and large institutions have $861M invested in Enfusion, Inc. in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,317% more call options, than puts

Call options by funds: $445K | Put options by funds: $6K

145% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 22

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

11% more capital invested

Capital invested by funds: $774M → $861M (+$87.9M)

8% more funds holding

Funds holding: 101109 (+8)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
109
Holders Change
+8
Holders Change %
+7.92%
% of All Funds
1.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
54
Reduced
22
Closed
9
Calls
$445K
Puts
$6K
Net Calls
+$439K
Net Calls Change
+$36K
Name Holding Trade Value Shares
Change
Change in
Stake
AI
26
Atom Investors
Texas
$2.4M +$50.5K +5,858 +2%
CC
27
Clearline Capital
New York
$2.33M +$535K +61,971 +34%
JP Morgan Chase
28
JP Morgan Chase
New York
$1.97M +$1.54M +178,821 +612%
GC
29
Globeflex Capital
California
$1.36M -$394K -45,653 -24%
Renaissance Technologies
30
Renaissance Technologies
New York
$1.32M +$366K +42,400 +44%
2C
31
272 Capital
Texas
$1.32M
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.16M -$320K -37,046 -23%
ECM
33
ExodusPoint Capital Management
New York
$1.16M +$1.05M +122,167 New
State Board of Administration of Florida Retirement System
34
State Board of Administration of Florida Retirement System
Florida
$1.16M -$185K -21,454 -15%
Goldman Sachs
35
Goldman Sachs
New York
$1.14M +$610K +70,741 +144%
RAM
36
Readystate Asset Management
Illinois
$1.04M +$598K +69,328 +174%
RA
37
Royce & Associates
New York
$946K +$225K +26,045 +35%
N
38
Nuveen
North Carolina
$909K
SG Americas Securities
39
SG Americas Securities
New York
$892K +$811K +94,032 New
PP
40
PDT Partners
New York
$867K +$788K +91,315 New
Lazard Asset Management
41
Lazard Asset Management
New York
$860K +$720K +83,384 +1,152%
Barclays
42
Barclays
United Kingdom
$817K +$531K +61,554 +251%
Hudson Bay Capital Management
43
Hudson Bay Capital Management
Connecticut
$774K -$778K -90,108 -52%
CM
44
CastleKnight Management
New York
$768K +$698K +80,900 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$767K +$95.8K +11,100 +16%
MAM
46
Martingale Asset Management
Massachusetts
$706K +$133K +15,424 +26%
GCM
47
Gladius Capital Management
Illinois
$661K +$371K +42,939 +160%
BFM
48
Boothbay Fund Management
New York
$625K
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$576K +$10.6K +1,233 +2%
UBS Group
50
UBS Group
Switzerland
$553K +$337K +39,085 +204%

ENFN Hedge Fund Activity: Q3 2024 in Review

109 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q3 2024, worth a combined $861M — up 11% from $774M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ENFN positions and 9 closed out — a net gain of 10 holders — while 54 added to existing stakes and 22 trimmed.

The largest buyer was Lead Edge Capital Management, adding an estimated $5.82M. The largest seller was Brown Capital Management, cutting an estimated $11.8M.

  • 109 institutional investors held Enfusion, Inc. (ENFN) as of Q3 2024, up from 101 in Q2 2024.
  • Funds reported $861M of Enfusion, Inc. stock for Q3 2024, up 11% quarter-over-quarter.
  • 19 funds opened new Enfusion, Inc. positions in Q3 2024 and 9 closed out, a net change of +10 holders.
  • The largest Enfusion, Inc. buyer in Q3 2024 was Lead Edge Capital Management, an estimated $5.82M added.
  • The largest Enfusion, Inc. seller in Q3 2024 was Brown Capital Management, an estimated $11.8M sold.

Based on aggregated 13F filings for Q3 2024.